跳至主要内容
临床试验/EUCTR2021-005579-38-DK
EUCTR2021-005579-38-DK进行中(未招募)1 期

Cabergoline as a Preventive Treatment for Chronic Migraine: an Investigator-Initiated, Randomized Clinical Trial

Aarhus University Hospital, Department of Endocrinology0 个研究点目标入组 32 人开始时间: 2021年11月8日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Migraine and more than six days of headache /month
  • - Age = 18 years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 32
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 32

排除标准

  • - Known or suspected heart valve disease
  • - Severe, untreated hypertension
  • - Psychiatric disease requiring pharmacological treatment
  • - Treatment with dopamine receptor agonists
  • - Treatment with other medicine with known interaction with cabergoline
  • - Pregnancy or breastfeeding

研究者

发起方
Aarhus University Hospital, Department of Endocrinology

相似试验

Cabergoline as a Preventive Treatment for Chronic... | 临床试验